Payzone - It appears as if this trial that you are looking at had nothing to do with the trial that ZEN-3694, Keytruda and Xtandi(ensalutamide) are in. The trial in the article you attached had 1200 patients in it. The trial we are in with UCSF and others had less than 50 patients at the time of the Zenith AGM on 27 Oct 2022. The AGM presentation is no longer on the Zenith website however there is a poster dated Aug 2022 referencing the trial we are in at the UCSF with 30% and 38% ORRs. 

Maybe the comment by one poster that suggested this didn't look good for us should be taken in stride.

If one of our board leaders has taken screen shots of the AGM presentation it would be nice if they could post them in the Link Library on this board.

tada